EP 1802294 A1 20070704 - CARBAMATE COMPOUNDS FOR USE IN TREATING NEURODEGENERATIVE DISORDERS
Title (en)
CARBAMATE COMPOUNDS FOR USE IN TREATING NEURODEGENERATIVE DISORDERS
Title (de)
CARBAMATVERBINDUNGEN ZUR VERWENDUNG BEI DER BEHANDLUNG NEURODEGENERATIVER ERKRANKUNGEN
Title (fr)
COMPOSES CARBAMATE DESTINES AU TRAITEMENT DE PATHOLOGIES NEURODEGENERATIVES
Publication
Application
Priority
- US 2005036695 W 20051014
- US 61940204 P 20041015
- US 69840305 P 20050712
Abstract (en)
[origin: WO2006044472A1] This invention is directed to methods for providing neuroprotection comprising administering to a subject in need thereof a therapeutically effective amount of a compound selected from the group consisting of Formula (I) and Formula (II), or a pharmaceutically acceptable salt or ester thereof,: Formula (I) Formula (II) wherein phenyl is substituted at X with one to five halogen atoms selected from the group consisting of fluorine, chlorine, bromine and iodine; and, R<sub
IPC 8 full level
A61K 31/27 (2006.01); A61P 25/28 (2006.01)
CPC (source: EP KR)
A61K 31/216 (2013.01 - KR); A61K 31/27 (2013.01 - EP); A61P 3/00 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 7/02 (2017.12 - EP); A61P 9/02 (2017.12 - EP); A61P 9/08 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 17/02 (2017.12 - EP); A61P 19/08 (2017.12 - EP); A61P 21/02 (2017.12 - EP); A61P 21/04 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/08 (2017.12 - EP); A61P 25/10 (2017.12 - EP); A61P 25/14 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 25/36 (2017.12 - EP); A61P 27/02 (2017.12 - EP); A61P 27/06 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 37/02 (2017.12 - EP)
C-Set (source: EP)
Citation (search report)
See references of WO 2006044472A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK YU
DOCDB simple family (publication)
WO 2006044472 A1 20060427; AU 2005295787 A1 20060427; BR PI0516112 A 20080826; CA 2584854 A1 20060427; EA 200700871 A1 20071026; EC SP077395 A 20070530; EP 1802294 A1 20070704; IL 182432 A0 20070920; JP 2008516961 A 20080522; KR 20070085309 A 20070827; KR 20090130175 A 20091218; KR 20110049901 A 20110512; MX 2007004491 A 20070808; NI 200700094 A 20080211; NO 20072444 L 20070614; SG 142306 A1 20080528
DOCDB simple family (application)
US 2005036695 W 20051014; AU 2005295787 A 20051014; BR PI0516112 A 20051014; CA 2584854 A 20051014; EA 200700871 A 20051014; EC SP077395 A 20070413; EP 05810159 A 20051014; IL 18243207 A 20070410; JP 2007536843 A 20051014; KR 20077010744 A 20070511; KR 20097019737 A 20051014; KR 20117007395 A 20051014; MX 2007004491 A 20051014; NI 200700094 A 20051014; NO 20072444 A 20070511; SG 2008028771 A 20051014